Who owns Eagle Pharmaceuticals?
- Ticker: EGRX
- CUSIP Number: 269796108
Tip: Access positions for across all investors
Analyze quarterly positions in Eagle Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eagle Pharmaceuticals stock
Who bought or sold Eagle Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 3.4M | $13M | 13% | Sep 2024 |
|
| AIGH Capital Management | 1.2M | $4.5M | 0% | Sep 2024 |
|
| Citigroup | 1.0M | $3.7M | 0% | Sep 2024 |
|
| Vanguard Group | 564k | $3.2M | -12% | Jun 2024 |
|
| AQR Capital Management | 375k | $1.4M | -46% | Sep 2024 |
|
| BlackRock | 353k | $2.0M | -61% | Jun 2024 |
|
| Morgan Stanley | 300k | $1.7M | -20% | Jun 2024 |
|
| BlackRock | 268k | $1.0M | 100% | Sep 2024 |
|
| Renaissance Technologies | 256k | $956k | 5% | Sep 2024 |
|
| Two Sigma Advisers | 225k | $1.3M | -5% | Jun 2024 |
|
| Marshall Wace | 223k | $833k | 14% | Sep 2024 |
|
| J. Goldman & Co | 191k | $1.1M | -26% | Jun 2024 |
|
| Assenagon Asset Management | 184k | $685k | -1% | Sep 2024 |
|
| Two Sigma Investments | 134k | $750k | -18% | Jun 2024 |
|
| Jacobs Levy Equity Management | 122k | $453k | 100% | Sep 2024 |
|
| Tang Capital Management | 119k | $443k | 0% | Sep 2024 |
|
| Geode Capital Management | 106k | $395k | -2% | Sep 2024 |
|
| Invesco | 83k | $309k | 0% | Sep 2024 |
|
| Goldman Sachs Group | 79k | $443k | -56% | Jun 2024 |
|
| AJOVista | 56k | $211k | 402% | Sep 2024 |
|
| D. E. Shaw & Co | 55k | $204k | -68% | Sep 2024 |
|
| Bank of America Corporation | 51k | $190k | -84% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 49k | $182k | 0% | Sep 2024 |
|
| Trexquant Investment | 44k | $163k | -17% | Sep 2024 |
|
| Royal Bank of Canada | 37k | $138k | -2% | Sep 2024 |
|
| State Street Corporation | 36k | $201k | -83% | Jun 2024 |
|
| Northern Trust | 32k | $119k | -68% | Sep 2024 |
|
| Bridgeway Capital Management | 32k | $179k | 0% | Jun 2024 |
|
| PDT Partners | 30k | $112k | 0% | Sep 2024 |
|
| Citadel Advisors | 27k | $101k | 100% | Sep 2024 |
|
| Jane Street | 26k | $96k | 100% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 18k | $67k | -26% | Sep 2024 |
|
| Squarepoint Ops | 18k | $100k | 100% | Jun 2024 |
|
| Qube Research & Technologies | 17k | $94k | 372% | Jun 2024 |
|
| Creative Planning | 16k | $59k | 100% | Sep 2024 |
|
| JustInvest | 16k | $58k | 14% | Sep 2024 |
|
| Barclays | 15k | $56k | -21% | Sep 2024 |
|
| Royce & Associates | 14k | $52k | 0% | Sep 2024 |
|
| T. Rowe Price Associates | 13k | $50k | 0% | Sep 2024 |
|
| Hsbc Holdings | 13k | $66k | 0% | Jun 2024 |
|
| William Blair $ Company | 13k | $48k | -1% | Sep 2024 |
|
| Stanley-Laman | 12k | $45k | 0% | Sep 2024 |
|
| Jump Financial | 11k | $40k | -12% | Sep 2024 |
|
| Russell Investments | 9.8k | $55k | 324% | Jun 2024 |
|
| Simplex Trading | 8.4k | $31k | 100% | Sep 2024 |
|
| State of Wyoming | 8.1k | $46k | -63% | Jun 2024 |
|
| Point72 Asia | 7.8k | $29k | -33% | Sep 2024 |
|
| Acadian Asset Management | 7.2k | $26k | -73% | Sep 2024 |
|
| Cubist Systematic Strategies | 6.2k | $23k | -76% | Sep 2024 |
|
| WealthCollab | 5.6k | $21k | 6% | Sep 2024 |
|
| Tower Research Capital | 3.2k | $18k | -10% | Jun 2024 |
|
| HighMark Wealth Management | 2.2k | $8.2k | 100% | Sep 2024 |
|
| Headlands Technologies | 1.7k | $6.2k | 100% | Sep 2024 |
|
| Group One Trading | 785.00 | $2.9k | 100% | Sep 2024 |
|
| Macquarie Group | 518.00 | $2.9k | 100% | Jun 2024 |
|
| Archer Investment Corp | 350.00 | $1.3k | 0% | Sep 2024 |
|
| Capital Advisors | 149.00 | $999.998600 | 0% | Sep 2024 |
|
| Advisor Group Holdings | 105.00 | $390.999000 | -37% | Sep 2024 |
|
| Farther Finance Advisors | 64.00 | $239.001600 | 0% | Sep 2024 |
|
| Global Retirement Partners | 49.00 | $183.000300 | 0% | Sep 2024 |
|
| Front Row Advisors | 40.00 | $149.000000 | 0% | Sep 2024 |
|
| Credit Agricole | 36.00 | $133.999200 | 100% | Sep 2024 |
|
| Pnc Financial Services | 28.00 | $104.000400 | 0% | Sep 2024 |
|
Who sold out of Eagle Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| LSV Asset Management | Jun 2024 | 295k | $1.7M |
| Perceptive Advisors | Jun 2024 | 173k | $971k |
| Millennium Management | Jun 2024 | 168k | $940k |
| Thomas Stevens, CFA" | Jun 2024 | 133k | $743k |
| Kennedy Capital Management | Mar 2024 | 56k | $292k |
| Charles Schwab Investment Management | Jun 2024 | 51k | $283k |
| Nuveen Asset Management | Mar 2024 | 42k | $221k |
| Wintrust Financial Corporation | Jun 2024 | 24k | $132k |
| Alliancebernstein | Mar 2024 | 21k | $112k |
| XTX Topco | Jun 2024 | 20k | $113k |
| Fidelis Capital Partners | Jun 2024 | 13k | $54k |
| Mackenzie Financial | Jun 2024 | 11k | $60k |
| Susquehanna International | Jun 2024 | 10k | $58k |
| Sei Investments | Mar 2024 | 10k | $54k |
| Rhumbline Advisers | Jun 2024 | 7.2k | $41k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 4.9k | $27k |
| Jpmorgan Chase & Co | Jun 2024 | 2.3k | $13k |
| CWM | Jun 2024 | 1.7k | $9.0k |
| Quantbot Technologies | Mar 2024 | 1.2k | $6.3k |
| Wells Fargo & Company | Jun 2024 | 351.00 | $2.0k |
| New York State Common Retirement Fund | Jun 2024 | 90.00 | $999.999000 |